These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9384617)

  • 1. The protective impact of a covariate on competing failures with an example from a bone marrow transplantation study.
    Di Serio C
    Lifetime Data Anal; 1997; 3(2):99-122. PubMed ID: 9384617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A note on including time-dependent covariate in regression model for competing risks data.
    Latouche A; Porcher R; Chevret S
    Biom J; 2005 Dec; 47(6):807-14. PubMed ID: 16450853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?
    Pepe MS; Mori M
    Stat Med; 1993 Apr; 12(8):737-51. PubMed ID: 8516591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
    Katsahian S; Resche-Rigon M; Chevret S; Porcher R
    Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian variable selection for the Cox regression model with missing covariates.
    Ibrahim JG; Chen MH; Kim S
    Lifetime Data Anal; 2008 Dec; 14(4):496-520. PubMed ID: 18836829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Bradley BA; Hows JM; Gore SM; Bidwell JL; Clay T; Downie TR; Gluckman E; Howard MR; Laundy GJ
    Clin Transpl; 1992; ():91-107. PubMed ID: 1306726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudo-observations for competing risks with covariate dependent censoring.
    Binder N; Gerds TA; Andersen PK
    Lifetime Data Anal; 2014 Apr; 20(2):303-15. PubMed ID: 23430270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Hows J; Bradley BA; Gore S; Downie T; Howard M; Gluckman E
    Bone Marrow Transplant; 1993 Oct; 12(4):371-80. PubMed ID: 8275037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating and testing for center effects in competing risks.
    Katsahian S; Boudreau C
    Stat Med; 2011 Jun; 30(13):1608-17. PubMed ID: 21341296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-parametric inferences for association with semi-competing risks data.
    Ghosh D
    Stat Med; 2006 Jun; 25(12):2059-70. PubMed ID: 16196081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic pseudo-observations: a robust approach to dynamic prediction in competing risks.
    Nicolaie MA; van Houwelingen JC; de Witte TM; Putter H
    Biometrics; 2013 Dec; 69(4):1043-52. PubMed ID: 23865523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-mismatched bone marrow transplantation in thalassemia.
    Polchi P; Galimberti M; Lucarelli G; Baronciani D; Giardini C; Angelucci E; De Biagi M; Donati M
    Bone Marrow Transplant; 1993; 12 Suppl 1():67-9. PubMed ID: 8374569
    [No Abstract]   [Full Text] [Related]  

  • 17. The graft-versus-leukaemia effect after allogeneic bone-marrow transplantation: assessment through competing risks approaches.
    Katsahian S; Porcher R; Mary JY; Chevret S
    Stat Med; 2004 Dec; 23(24):3851-63. PubMed ID: 15580602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.
    Klein JP; Rizzo JD; Zhang MJ; Keiding N
    Bone Marrow Transplant; 2001 Nov; 28(10):909-15. PubMed ID: 11753543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study.
    Gahrton G; Tura S; Ljungman P; Belanger B; Brandt L; Cavo M; Chapuis B; De Laurenzi A; de Witte T; Facon T
    Bone Marrow Transplant; 1991; 7 Suppl 2():32. PubMed ID: 1878706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.